Freedman Financial Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,600
Closed -$160K 85
2022
Q1
$160K Buy
1,600
+1
+0.1% +$105 0.11% 90
2021
Q4
$165K Sell
1,599
-100
-6% -$9.24K 0.11% 87
2021
Q3
$144K Buy
1,699
+104
+7% +$8.71K 0.11% 89
2021
Q2
$133K Buy
1,595
+97
+6% +$7.94K 0.1% 91
2021
Q1
$113K Buy
1,498
+2
+0.1% +$146 0.09% 96
2020
Q4
$102K Buy
+1,496
New +$97.3K 0.09% 93

Other funds holding CVS

Freedman Financial Associates's CVS Position: Q2 2022 in Review

Freedman Financial Associates sold out of CVS Health (CVS) in Q2 2022, closing a stake of 1,600 shares — an estimated $160K sold.

Freedman Financial Associates first reported a position in CVS in Q4 2020 and held it in 6 quarters. The position peaked at $165K in Q4 2021. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Freedman Financial Associates reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 1,600 CVS Health shares in Q2 2022, an estimated $160K.
  • Freedman Financial Associates first reported a position in CVS Health in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's CVS Health position peaked at $165K in Q4 2021.
  • 2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.